Skip to main content
Premium Trial:

Request an Annual Quote

The Phenome's New Home

The Olympics will be over soon, so what will London do with all the facilities it built for the games? The UK government-funded Medical Research Council and National Institute for Health Research have a plan for the Olympics anti-doping laboratory, says ScienceInsider's Angela Saini — they're going to turn it into a center for the study of the phenome. The new MRC-NIHR Phenome Centre will be dedicated to research on "metabolic phenotyping, a field that examines blood, urine, and tissues for the thousands of molecules produced by the body's chemical reactions, with the aim of linking them up to diseases," she adds.

The lab already has mass spectrometers and instruments for high-performance liquid chromatography and gas chromatography, and MRC and NIHR are each chipping in £5 million to buy more instruments and support the staff, Saini says. The buildings belong to GlaxoSmithKline, which originally partnered with researchers at King's College London for the anti-doping lab. Bruker BioSpin and Waters will provide the extra instrumentation, she adds. The center will be switched over to MRC and NIHR in October, and they hope to open its doors in January.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.